392 related articles for article (PubMed ID: 18178665)
1. Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD).
Oglesbee D; Sanders KA; Lacey JM; Magera MJ; Casetta B; Strauss KA; Tortorelli S; Rinaldo P; Matern D
Clin Chem; 2008 Mar; 54(3):542-9. PubMed ID: 18178665
[TBL] [Abstract][Full Text] [Related]
2. An improved ultra performance liquid chromatography-tandem mass spectrometry method for the determination of alloisoleucine and branched chain amino acids in dried blood samples.
Alodaib A; Carpenter K; Wiley V; Sim K; Christodoulou J; Wilcken B
Ann Clin Biochem; 2011 Sep; 48(Pt 5):468-70. PubMed ID: 21775576
[TBL] [Abstract][Full Text] [Related]
3. Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms.
Puckett RL; Lorey F; Rinaldo P; Lipson MH; Matern D; Sowa ME; Levine S; Chang R; Wang RY; Abdenur JE
Mol Genet Metab; 2010 Jun; 100(2):136-42. PubMed ID: 20307994
[TBL] [Abstract][Full Text] [Related]
4. Quantification of Branched-Chain Amino Acids in Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Piri-Moghadam H; Miller A; Pronger D; Vicente F; Charrow J; Haymond S; Lin DC
Methods Mol Biol; 2022; 2546():65-81. PubMed ID: 36127579
[TBL] [Abstract][Full Text] [Related]
5. Chromatographic diagnosis of maple syrup urine disease by measuring the L-alloisoleucine/L-phenylalanine ratio in dried blood spots.
Jeong JS; Sim HJ; Lee YM; Yoon HR; Kwon HJ; Hong SP
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2171-4. PubMed ID: 21680261
[TBL] [Abstract][Full Text] [Related]
6. Application of liquid chromatography-tandem mass spectrometry in the diagnosis and follow-up of maple syrup urine disease in a Chinese population.
Lin N; Ye J; Qiu W; Han L; Zhang H; Gu X
J Pediatr Endocrinol Metab; 2013; 26(5-6):433-9. PubMed ID: 23412862
[TBL] [Abstract][Full Text] [Related]
7. Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry.
Chace DH; Hillman SL; Millington DS; Kahler SG; Roe CR; Naylor EW
Clin Chem; 1995 Jan; 41(1):62-8. PubMed ID: 7813082
[TBL] [Abstract][Full Text] [Related]
8. Quantification of branched-chain amino acids in blood spots and plasma by liquid chromatography tandem mass spectrometry for the diagnosis of maple syrup urine disease.
Sowell J; Pollard L; Wood T
J Sep Sci; 2011 Mar; 34(6):631-9. PubMed ID: 21328532
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.
Heldt K; Schwahn B; Marquardt I; Grotzke M; Wendel U
Mol Genet Metab; 2005 Apr; 84(4):313-6. PubMed ID: 15781191
[TBL] [Abstract][Full Text] [Related]
10. Recall rate and positive predictive value of MSUD screening is not influenced by hydroxyproline.
Fingerhut R
Eur J Pediatr; 2009 May; 168(5):599-604. PubMed ID: 18682982
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of maple syrup urine disease by determination of L-valine, L-isoleucine, L-leucine and L-phenylalanine in neonatal blood spots by gas chromatography-mass spectrometry.
Deng C; Deng Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(2):261-8. PubMed ID: 12860033
[TBL] [Abstract][Full Text] [Related]
12. Direct analysis of dried blood spots by in-line desorption combined with high-resolution chromatography and mass spectrometry for quantification of maple syrup urine disease biomarkers leucine and isoleucine.
Miller JH; Poston PA; Karnes HT
Anal Bioanal Chem; 2011 Apr; 400(1):237-44. PubMed ID: 21331490
[TBL] [Abstract][Full Text] [Related]
13. Exploratory Untargeted Metabolomics of Dried Blood Spot Samples from Newborns with Maple Syrup Urine Disease.
Alotaibi AZ; AlMalki RH; Al Mogren M; Sebaa R; Alanazi M; Jacob M; Alodaib A; Alfares A; Abdel Rahman AM
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891907
[TBL] [Abstract][Full Text] [Related]
14. Implications of Maple Syrup Urine Disease in Newborns.
Harris-Haman P; Brown L; Massey S; Ramamoorthy S
Nurs Womens Health; 2017; 21(3):196-206. PubMed ID: 28599741
[TBL] [Abstract][Full Text] [Related]
15. Maple syrup urine disease: magnetic resonance imaging findings in three patients.
Allahwala A; Ahmed S; Afroze B
J Pak Med Assoc; 2021 Apr; 71(4):1309-1313. PubMed ID: 34125801
[TBL] [Abstract][Full Text] [Related]
16. [Maple Syrup Urine Disease in a newborn infant].
Mazur A; Sykut-Cegielska J; Ciebiera M; Trzeciak J; Taybert J; Kowalik A; Ołtarzewski M
Med Wieku Rozwoj; 2007; 11(1):65-8. PubMed ID: 17965467
[TBL] [Abstract][Full Text] [Related]
17. Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease.
Schadewaldt P; Bodner-Leidecker A; Hammen HW; Wendel U
Clin Chem; 1999 Oct; 45(10):1734-40. PubMed ID: 10508118
[TBL] [Abstract][Full Text] [Related]
18. Maple syrup urine disease (MSUD)--clinical profile of 47 Filipino patients.
Lee JY; Chiong MA; Estrada SC; Cutiongco-De la Paz EM; Silao CL; Padilla CD
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S281-5. PubMed ID: 18989748
[TBL] [Abstract][Full Text] [Related]
19. [Advances in the diagnosis and treatment of maple syrup urine disease: experience in Galicia (Spain)].
Couce Pico ML; Castiñeiras Ramos DE; Bóveda Fontán MD; Iglesias Rodríguez AJ; Cocho de Juan JA; Fraga Bermúdez JM
An Pediatr (Barc); 2007 Oct; 67(4):337-43. PubMed ID: 17949643
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
